Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

Vincristine EP Impurity C

Vincristine EP Impurity C is listed in the pharmaceutical impurity collection under CAS 18172-50-4. Its represented structure has formula C45H56N4O9 and a calculated molecular weight of 796.96 g/mol.

2D chemical structure

H O N N H O O O N H O H O O O O N H H H ( S ) ( R ) ( S ) ( R ) ( S ) ( R ) ( R ) ( S ) ( R )

Chemical identity

Catalog name
Vincristine EP Impurity C
Common name
Vincristine EP Impurity C
Chemical name
Not available
CAS
18172-50-4
SMILES
CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1
InChI
InChI=1S/C45H56N4O9/c1-7-41(53)22-27-23-44(39(51)56-5,35-29(14-18-48(24-27)25-41)28-12-9-10-13-32(28)46-35)31-20-30-33(21-34(31)55-4)47-36-43(30)16-19-49-17-11-15-42(8-2,37(43)49)38(58-26(3)50)45(36,54)40(52)57-6/h9-13,15,20-21,27,36-38,46-47,53-54H,7-8,14,16-19,22-25H2,1-6H3/t27-,36+,37-,38+,41-,42+,43-,44-,45-/m0/s1
InChIKey
OBEIXXHHUOSBLA-UQUCNHJPSA-N
Associated API
Vincristine

Record ID: Ae64d123dee0a

Computed properties

C45H56N4O9 Molecular formula
796.962 g/molMolecular weight
796.4047 DaMonoisotopic exact mass
162.89 ŲTopological polar surface area
3.9666 Calculated LogP (Wildman–Crippen)
215.648 cm³/molMolar refractivity (Wildman–Crippen)
12 countHydrogen-bond acceptors
4 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD. 1 potential atom stereocenters have unspecified configuration.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 4 8 12 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C H N O 0 15 30 45 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight796.96296.81
Calculated LogP (Wildman–Crippen)3.966678.05
Topological polar surface area162.8991.29
Hydrogen-bond acceptors1295.82
Hydrogen-bond donors489.70
Rotatable bonds (strict)776.94

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC45H56N4O9dimensionless
Molecular weight796.962g/mol
Monoisotopic exact mass796.4047Da
Topological polar surface area162.89Ų
Calculated LogP (Wildman–Crippen)3.9666dimensionless
Molar refractivity (Wildman–Crippen)215.648cm³/mol
Hydrogen-bond acceptors12count
Hydrogen-bond donors4count
Rotatable bonds (strict)7count
Heavy atoms58count
Heteroatoms13count
Rings9count
Aromatic rings3count
Aliphatic rings6count
Saturated rings3count
Aromatic heterocycles1count
Aliphatic heterocycles5count
Saturated heterocycles2count
Aromatic carbocycles2count
Aliphatic carbocycles1count
Fraction of sp³ carbon atoms0.5778fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters10count
Unspecified atom stereocenters1count
Spiro atoms1count
Bridgehead atoms2count
Labute approximate surface area338.5647Ų
Valence electrons310count
Radical electrons0count
Bertz complexity2,221.8629index
Balaban J1.3444index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for Vincristine EP Impurity C

Qualification and safety assessment of Vincristine EP Impurity C

Explore toxicological qualification of Vincristine EP Impurity C and ICH M7 mutagenic impurity assessment of Vincristine EP Impurity C for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for Vincristine EP Impurity C and acceptable intake and limit justification for Vincristine EP Impurity C. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Other catalogue designations with the same represented structure

These are separate catalogue entries; shared structure does not establish interchangeable pharmacopoeial designations.

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for Vincristine EP Impurity C

Explore Altox services and software through the Altox Pharma-Hub.